Evaluation of Serum Level of Human Beta Defensin 1 in Patients With Alopecia Areata

October 2022 in “ Benha Journal of Applied Sciences ”

A.A. Abd El-moneam, A.A. Ebrahim, A.I. Mustafa, W.A. Abd-Halim

human beta defensin 1 alopecia areata autoimmune disease non-scarring hair loss HBD-1 AA

TLDR Human Beta Defensin 1 levels do not predict the risk or severity of Alopecia Areata.

The study "Evaluation of serum Level of Human Beta Defensin 1 patients With Alopecia Areata" conducted by A.A. Ebrahim, A.I. Mustafa, and W.A. Abd-Halim from the Dermatology Venereology and Andrology Dept., Faculty of Medicine, Benha Univ., Benha, Egypt, aimed to understand the role of human beta defensin 1 (HBD-1) in the pathogenesis of alopecia areata (AA), an autoimmune disease causing non-scarring hair loss. The prospective case-control study involved 40 patients with AA and 40 age and sex-matched healthy subjects. The results showed no significant difference in serum levels of HBD-1 between the AA group and the control group (p=0.03). The study concluded that HBD-1 concentration is not a predictor of AA susceptibility and severity.

View this study on bjas.journals.ekb.eg →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community Possible topical option for preventing BDNF-related hair loss

in Research/Science 7 upvotes 1 year ago

The conversation discusses hair loss linked to BDNF-increasing nootropics like Semax and Lions Mane. Suggested topical treatments include capsaicin, beta-glucan, and ginseng to counteract TGF-B activation.

community A concise, easy-to-understand post on Androgenic Alopecia theory and its practical applications

in Research/Science 92 upvotes 3 years ago

The mechanism of Androgenic Alopecia and practical applications of treatments like Minoxidil, Finasteride, RU58841, dermarolling, scalp massages, anti-fungals, progesterone, estrogen, PPAR-γ activators, reducing oxidative stress, and scalp exercises. It explains why DHT is important in AA and how other factors might be involved such as hypoxia, increased DKK-1 expression, morphological changes to the scalp, skull growth during childhood/puberty, and blood flow.

community CRISPR Is Curing People Right Now. Genetic Hair Loss is Next?

in Technology 107 upvotes 9 months ago

CRISPR shows promise for treating hair loss by targeting specific genes. Current treatments include Minoxidil and finasteride, but CRISPR could offer a more precise solution, though it is still expensive and in early stages.

community The meds work: my dad at 23 yo vs me at 35 yo

in Finasteride/Dutasteride 1748 upvotes 2 weeks ago

Finasteride and oral minoxidil effectively maintain a youthful appearance and full head of hair, despite genetic predispositions to balding. The discussion also considers the impact of DHT blockers on masculinity and aging, with lifestyle choices like sunscreen use and a vegetarian diet mentioned.

community My progress with various products and without oral fin or oral dut on 17 months

in Progress Pictures 61 upvotes 3 weeks ago

The user shared their hair loss treatment progress using topical products like exosomes, fluridil, Kx826, and topical dutasteride, avoiding oral finasteride and dutasteride due to side effects. They found exosomes from Creative Biolabs most effective and also used topical probiotics, noting improvements without significant side effects.

community Holy shit. Verteporfin may actually be the cure

in Research/Science 1015 upvotes 1 year ago

The post and conversation discuss Verteporfin's potential as a hair loss treatment. It's shown promise in regrowing hair after transplants and might be effective with microneedling.

Related Research

3 / 3 results

research Twenty Nail Dystrophy with Alopecia Areata in an Atopic Child

April 2019 in “International journal of research in dermatology”

A child with rough nails also had hair loss and allergies.

research Oral Tofacitinib: A Promising Treatment in Atopic Dermatitis, Alopecia Areata, and Vitiligo

37 citations, October 2017 in “Clinical and Experimental Dermatology”

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

research Vitiligo After Diphencyprone for Alopecia Areata

18 citations, January 2010 in “Dermatology Research and Practice”

DPCP treatment for alopecia areata can sometimes cause vitiligo.